Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.

[1]  S. Freedland,et al.  Associations of benign prostatic hyperplasia with prostate cancer: the debate continues. , 2011, European urology.

[2]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[3]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[4]  P. Vedsted,et al.  [Use of prostate-specific antigen testing]. , 2010, Ugeskrift for laeger.

[5]  I. Thompson,et al.  Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[6]  I. Thompson,et al.  Serum adiponectin, C‐peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial , 2009, The Prostate.

[7]  I. Thompson,et al.  Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. , 2008, American journal of epidemiology.

[8]  D. Tindall,et al.  The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer. , 2008, The Journal of urology.

[9]  P. Mortensen,et al.  The Danish Civil Registration System. A cohort of eight million persons. , 2006, Danish medical bulletin.

[10]  K. McVary.  BPH: epidemiology and comorbidities. , 2006, The American journal of managed care.

[11]  D. Bostwick,et al.  Human prostate cancer risk factors , 2004, Cancer.

[12]  H. Adami,et al.  Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia , 2003, Cancer.

[13]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[14]  B. Högstedt,et al.  Calculated Fast-growing Benign Prostatic Hyperplasia , 2002, Scandinavian journal of urology and nephrology.

[15]  T. Nickelsen,et al.  [Data validity and coverage in the Danish National Health Registry. A literature review]. , 2001, Ugeskrift for laeger.

[16]  H. Guess.  Benign prostatic hyperplasia and prostate cancer. , 2001, Epidemiologic reviews.

[17]  K. Juel,et al.  The Danish registers of causes of death. , 1999, Danish medical bulletin.

[18]  T. F. Andersen,et al.  The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.

[19]  H. Sørensen,et al.  The Danish prescription registries. , 1997, Danish medical bulletin.

[20]  J. Oesterling,et al.  Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? , 1995, Urology.

[21]  A. Morrison,et al.  The relation of surgery for prostatic hypertrophy to carcinoma of the prostate. , 1993, American journal of epidemiology.

[22]  P. Greenwald,et al.  Cancer of the prostate among men with benign prostatic hyperplasia. , 1974, Journal of the National Cancer Institute.

[23]  A. Lilienfeld,et al.  Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. , 1974, Lancet.

[24]  C. Letourneau.  CLASSIFICATION OF SURGICAL PROCEDURES. , 1965, Hospital management.